Skip to content

Lucid Diagnostics LUCD Debt Repayments

Debt Repayments at other companies

Biodesix, Inc. logo
Biodesix, Inc.BDSX
$5K-28.6%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$476K+1.3%
GeneDx Holdings logo
GeneDx HoldingsWGS
$2M
Quest Diagnostics logo
Quest DiagnosticsDGX
$1M-99.8%
Labcorp Holdings logo
Labcorp HoldingsLH
$0-100%
Danaher logo
DanaherDHR
$1.43B

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfConvertibleDebt.

The official record: Lucid Diagnostics’s 10-K, filed March 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's debt repayments?
Lucid Diagnostics (LUCD) reported debt repayments of -$0 in Q4 2025.
How has Lucid Diagnostics's debt repayments changed year-over-year?
Lucid Diagnostics's debt repayments decreased by 100.0% year-over-year, from $904K to -$0.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.